Compare Ezra to the traditional prostate cancer screening approach: a PSA blood test, followed by a prostate biopsy if PSA levels are elevated. Studies have shown that PSA levels are often inaccurate, resulting in overdiagnosis and unnecessary biopsies. Not to mention that prostate biopsies may have side effects such as bleeding, infection, urinary issues, and erectile dysfunction1.
A recent study concluded that if prostate biopsies were directed by MRI findings, up to 18% more cases of clinically significant cancer might be detected compared with the standard pathway of prostate biopsy for all. Furthermore, using MRI to triage men might allow 27% of patients to avoid an unnecessary biopsy, and all the complications that may come with it2.